The expert panel in hematology examines recent WHO and ICC guideline updates, evaluating their impact on the evolving treatment landscape for myelodysplastic syndromes.
Dr Garcia-Manero to Panel: How have the updates to WHO (Garcia-Manero G. Am J Hematol. 2023) and ICC guidelines impacted how you identify, diagnose, and classify myelodysplastic syndromes?